WA
AGN

Winfield Associates’s Allergan plc AGN Stock Holding History

Winfield Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-80
Closed -$14K – 760
2017
Q4 		$14K Buy
80
+10
+14% +$1.79K 0.01% 381
2017
Q3 		$14K Sell
70
-21
-23% -$4.88K 0.01% 366
2017
Q2 		$22K Buy
91
+21
+30% +$4.93K 0.01% 281
2017
Q1 		$17K Hold
70
– – 0.01% 296
2016
Q4 		$15K Sell
70
-10
-13% -$2.07K 0.01% 311
2016
Q3 		$18K Buy
80
+5
+7% +$1.22K 0.01% 268
2016
Q2 		$17K Buy
75
+5
+7% +$1.15K 0.01% 268
2016
Q1 		$19K Buy
+70
New +$20K 0.01% 246

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Winfield Associates's AGN Position: Q1 2018 in Review

Winfield Associates sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 80 shares — an estimated $14K sold.

Winfield Associates first reported a position in AGN in Q1 2016 and held it in 8 quarters. The position peaked at $22K in Q2 2017. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Winfield Associates reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 80 Allergan plc shares in Q1 2018, an estimated $14K.
  • Winfield Associates first reported a position in Allergan plc in Q1 2016 and held it in 8 quarters.
  • Winfield Associates's Allergan plc position peaked at $22K in Q2 2017.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.